Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
- PMID: 18056770
- DOI: 10.1210/jc.2007-2013
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
Abstract
Context: Few studies have systematically analyzed the long-term recurrence rates of Cushing's disease after initial successful transsphenoidal surgery.
Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center.
Patients: A total of 215 subjects with Cushing's disease who underwent initial transsphenoidal surgery for resection of a presumed pituitary microadenoma from 1992-2006 were included.
Main outcome measures: Remission and recurrence rates of Cushing's disease were examined. Recurrence was defined as an elevated 24-h urine free cortisol with clinical symptoms consistent with Cushing's disease.
Results: Of the 215 patients who underwent transsphenoidal surgery for Cushing's disease, surgical remission was achieved in 184 (85.6%). The mean length of follow-up was 45 months. Actuarial recurrence rates of Cushing's disease after initially successful transsphenoidal surgery at 1, 2, 3, and 5 yr were 0.5, 6.7, 10.8, and 25.5%, respectively. Among the 184 patients who achieved remission, 32 (17.4%) patients followed for more than 6 months ultimately had a recurrence of Cushing's disease. The median time to recurrence was 39 months. Immediate postoperative hypocortisolemia (serum cortisol < or = 2 microg/dl within 72-h surgery) was achieved in 97 (45.1%) patients. Patients who had postoperative serum cortisol of more than 2 microg/dl were 2.5 times more likely to have a recurrence than patients who had serum cortisol less than or equal to 2 microg/dl (odds ratio = 2.5; 95% confidence interval 1.12-5.52; P = 0.022).
Conclusions: A quarter of the patients with Cushing's disease who achieve surgical remission after transsphenoidal surgery, recur with long-term follow-up. This finding emphasizes the need for continued biochemical and clinical follow-up to ensure remission after surgery.
Similar articles
-
Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.BMC Endocr Disord. 2015 Oct 25;15:62. doi: 10.1186/s12902-015-0055-9. BMC Endocr Disord. 2015. PMID: 26499317 Free PMC article. Clinical Trial.
-
Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F. Neurosurgery. 2008. PMID: 18797356
-
Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.J Neurosurg. 2018 Nov 1;129(5):1268-1277. doi: 10.3171/2017.6.JNS17635. Epub 2017 Dec 22. J Neurosurg. 2018. PMID: 29271716
-
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.J Clin Endocrinol Metab. 1995 Nov;80(11):3114-20. doi: 10.1210/jcem.80.11.7593411. J Clin Endocrinol Metab. 1995. PMID: 7593411 Review.
-
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901. J Neurosurg. 2018. PMID: 29219752 Review.
Cited by
-
Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas.Surg Neurol Int. 2012;3(Suppl 2):S79-89. doi: 10.4103/2152-7806.95419. Epub 2012 Apr 26. Surg Neurol Int. 2012. PMID: 22826820 Free PMC article.
-
Mitotane (op'DDD) restores growth and puberty in nine children with Cushing's disease.Endocr Connect. 2018 Dec;7(12):1280-1287. doi: 10.1530/EC-18-0215. Endocr Connect. 2018. PMID: 30352417 Free PMC article.
-
The genomic profiling and MAMLD1 expression in human and canines with Cushing's disease.BMC Endocr Disord. 2021 Sep 13;21(1):185. doi: 10.1186/s12902-021-00845-z. BMC Endocr Disord. 2021. PMID: 34517852 Free PMC article.
-
Medical combination therapies in Cushing's disease.Pituitary. 2015 Apr;18(2):253-62. doi: 10.1007/s11102-015-0641-x. Pituitary. 2015. PMID: 25647330
-
Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.BMC Endocr Disord. 2015 Oct 25;15:62. doi: 10.1186/s12902-015-0055-9. BMC Endocr Disord. 2015. PMID: 26499317 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical